Literature DB >> 16533137

Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.

Ayda Tekok-Kilic1, Ralph H B Benedict, Robert Zivadinov.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, characterized by demyelination and neurodegeneration. Besides the sensory and motor deficits that are the hallmark of this disease, approximately 50% of MS patients are cognitively impaired. Over the years, structural neuroimaging has been used widely in MS patients for both diagnostic and research purposes. Various conventional and nonconventional magnetic resonance imaging (MRI) measures have provided important information about the degree and mechanisms of cerebral pathology, and these measures correlate with cognitive and affective disturbances. In this article, recent contributions to the literature regarding the correlation between MRI and neuropsychological function in MS are reviewed.

Entities:  

Mesh:

Year:  2006        PMID: 16533137     DOI: 10.1586/14737175.6.3.323

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

1.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

2.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.